Rincon lithium project: US$2.5bn cost, 60,000tpa capacity, DLE technology and 2028 production timeline
Read More Pharma Industry News Aldeyra Therapeutics brings biotech CFO experience to board amid ALDX regulatory reset Find out how Aldeyra Therapeutics’ new board appointment could shape ALDX stock sentiment, FDA strategy and reproxalap’s next chapter for investors now. byPallavi MadhirajuJune 10, 2026